What it's sold for

Muscle growth
Sleep quality
Appetite
Anti-aging

What has actually been tested

Growth Hormone Deficiency
Chronic Kidney Disease
Growth Hormone Deficiency (GHD)
Aging
Alzheimer's Disease
End Stage Renal Disease
Fibromyalgia
Hip Fracture

Is it studied for what it's sold for?

Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.

Studied Muscle growth

Not listed Sleep quality

Not listed Appetite

Not listed Anti-aging

Every trial on record

Every registered human study we can find for Ibutamoren. Click any ID to read the original record — we would rather you checked us than trusted us.

Trial ID	Title	Condition	Phase	Status	Enrolled
NCT06948214	Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency	Growth Hormone Deficiency (GHD)	Phase 3	Recruiting now	150
NCT07129759	Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency	Growth Hormone Deficiency (GHD)	Phase 3	Not yet recruiting	150
NCT04614337	Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)	Growth Hormone Deficiency	Phase 2	Completed	104
NCT00474279	Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults	Aging	Phase 2	Completed	72
NCT00074529	Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)	Alzheimer's Disease	Phase 2	Completed	512
NCT05364684	The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease	NAFLD, Nonalcoholic Fatty Liver	Phase 2	Completed	12
NCT05250063	Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)	Growth Hormone Deficiency	Phase 2	Completed	15
NCT00116129	Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia	Fibromyalgia	Phase 2	Completed	64
NCT00395291	Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients	Chronic Kidney Disease, End Stage Renal Disease	Not phased	Completed	49
NCT01343641	Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects	Chronic Kidney Disease, Kidney Disease	Phase 2	Withdrawn before enrolling	0 — nobody enrolled
NCT05796440	A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)	Growth Hormone Deficiency	Phase 2	ENROLLING_BY_INVITATION	60
NCT00128115	Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)	Hip Fracture	Phase 2	Stopped early	83
NCT04806854	PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)	Growth Hormone Deficiency	Phase 2	Running, closed to new participants	24

—Read this

A trial count is not a verdict

These numbers describe how much has been formally studied in humans, not whether something works or is safe for you. A compound can be tested for one condition and sold for another — which is usually the story. This page is automated aggregation from public registries; no physician has reviewed it. Take anything here to a clinician.

Why sources disagree on this number

Different sites publish different counts for Ibutamoren because they are answering different questions. Here is every way of counting the same set of studies, so you can see which rule produces which number.

Registered human trials the number we publish

Interventional studies in people, listed on ClinicalTrials.gov, at any status.

Completed

Registered trials whose status is "completed".

Still running

Recruiting, not yet recruiting, or active.

Stopped early

Terminated, withdrawn, or suspended.

With a stated phase

Registered trials tagged Phase 1-4.

100+ participants

Registered trials enrolling at least 100 people.

Observational studies

Studies that watch rather than intervene.

You may see a lower number than 13.

Sources that count only completed studies get 7. We count registered trials at any status, because a trial that is recruiting is still a real trial and is the thing most likely to change this page. Neither number is wrong; they answer different questions.

Some counts only include trials with a stated phase.

That yields 12 rather than 13. Not every registered study is tagged with a phase — some are marked "not applicable" — so phase-only counts run lower.

Which number should you use?

For "how much human evidence exists", 13 is the honest answer, with the caveat that 7 have actually finished. Every trial is listed on this page with its ID — if you disagree with how we count, you can recount it yourself in about a minute.

Common questions about Ibutamoren

How many human trials does Ibutamoren have?

13. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.

Is Ibutamoren FDA approved?

No. Ibutamoren is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.

What is Ibutamoren actually being tested for?

Registered studies cover: growth hormone deficiency (ghd), growth hormone deficiency, aging. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.

Where does this data come from?

ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.